Glipizide Extended-Release Tablets and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Glipizide Extended-Release Tablets and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glipizide
Brand name: Glucotrol, Glucotrol XL, Glipizide XL
Synonyms: Glipizide, GlipiZIDE
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glipizide Extended-Release Tablets-Tilia Fe
- Glipizide Extended-Release Tablets-Tiludronate
- Glipizide Extended-Release Tablets-Timentin
- Glipizide Extended-Release Tablets-Timentin Add-Vantage
- Glipizide Extended-Release Tablets-Timentin Injection
- Glipizide Extended-Release Tablets-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Glipizide Tablets
- Tildrakizumab-asmn Subcutaneous-Glipizide XL
- Tildrakizumab-asmn Subcutaneous-Glofil-125
- Tildrakizumab-asmn Subcutaneous-Gloperba
- Tildrakizumab-asmn Subcutaneous-GloStrips
- Tildrakizumab-asmn Subcutaneous-Glucagen